SAN FRANCISCO (MarketWatch) -- NxStage Medical Inc. said late Wednesday it has received Food and Drug Administration 510(k) clearance to market its PureFlow SL product. This device is used to prepare ...

NxStage Medical Inc. of Lawrence has received U.S. Food and Drug Administration clearance to market its PureFlow SL product, a device that prepares high-purity dialysate from ordinary tap water in the ...

NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

LAWRENCE, Mass., Aug. 28, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the U.S. Food and Drug ...

LAWRENCE, Mass., Aug. 24, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the NxStage® System One™ ...

LAWRENCE, Mass., Jan. 13, 2016 /PRNewswire/ -- To coincide with the sixth anniversary of the 2010 Haiti earthquake, NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, ...

LAWRENCE, Mass., Nov. 1, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced new findings in a series of ...